Cargando…

Enigma of pulmonary hypertension; echocardiography in the crossroads

Pulmonary hypertension (PH) with its myriad presentations provides a challenge in its diagnosis and management. Recent WHO classification of pulmonary hypertension as defined at the 5th World Symposium held in Nice, France in 2013 tries to highlight different forms of pulmonary hypertension based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Roychoudhury, Debasish, Sha, Kenneth, Nanda, Navin C., Gustafson, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452039/
https://www.ncbi.nlm.nih.gov/pubmed/32874908
http://dx.doi.org/10.1016/j.rmcr.2020.101181
_version_ 1783575095319461888
author Roychoudhury, Debasish
Sha, Kenneth
Nanda, Navin C.
Gustafson, Gregory
author_facet Roychoudhury, Debasish
Sha, Kenneth
Nanda, Navin C.
Gustafson, Gregory
author_sort Roychoudhury, Debasish
collection PubMed
description Pulmonary hypertension (PH) with its myriad presentations provides a challenge in its diagnosis and management. Recent WHO classification of pulmonary hypertension as defined at the 5th World Symposium held in Nice, France in 2013 tries to highlight different forms of pulmonary hypertension based on different pathophysiology, clinical presentation and therapeutic strategies [1]. These are classified in 5 groups as follows (1): PAH, (2) PH due to left heart disease, (3) PH due to chronic lung disease and/or hypoxia, (4) chronic thromboembolic PH (CTEPH), and (5) PH due to unclear or multifactorial mechanism. In clinical practice we encounter patients with pulmonary hypertension which is often very difficult to diagnose accurately and therefore presents with therapeutic challenge. Echocardiography plays a vital role in diagnosis and management of this enigmatic disease entity. Due to the complex nature of the disease, there can be some overlaps in various groups of pulmonary hypertension. This is particularly true about the two groups according to WHO classification-pulmonary arterial hypertension (WHO group 1) and chronic thromboembolic pulmonary hypertension (WHO group 3). As clinicians we are often faced with the dilemma of making the correct diagnosis and echocardiography plays a pivotal role in this crossroad. We want to present two cases of pulmonary hypertension with different etiologies as stated above and review literature to elucidate the role of echocardiogram in these cases.
format Online
Article
Text
id pubmed-7452039
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74520392020-08-31 Enigma of pulmonary hypertension; echocardiography in the crossroads Roychoudhury, Debasish Sha, Kenneth Nanda, Navin C. Gustafson, Gregory Respir Med Case Rep Case Report Pulmonary hypertension (PH) with its myriad presentations provides a challenge in its diagnosis and management. Recent WHO classification of pulmonary hypertension as defined at the 5th World Symposium held in Nice, France in 2013 tries to highlight different forms of pulmonary hypertension based on different pathophysiology, clinical presentation and therapeutic strategies [1]. These are classified in 5 groups as follows (1): PAH, (2) PH due to left heart disease, (3) PH due to chronic lung disease and/or hypoxia, (4) chronic thromboembolic PH (CTEPH), and (5) PH due to unclear or multifactorial mechanism. In clinical practice we encounter patients with pulmonary hypertension which is often very difficult to diagnose accurately and therefore presents with therapeutic challenge. Echocardiography plays a vital role in diagnosis and management of this enigmatic disease entity. Due to the complex nature of the disease, there can be some overlaps in various groups of pulmonary hypertension. This is particularly true about the two groups according to WHO classification-pulmonary arterial hypertension (WHO group 1) and chronic thromboembolic pulmonary hypertension (WHO group 3). As clinicians we are often faced with the dilemma of making the correct diagnosis and echocardiography plays a pivotal role in this crossroad. We want to present two cases of pulmonary hypertension with different etiologies as stated above and review literature to elucidate the role of echocardiogram in these cases. Elsevier 2020-08-03 /pmc/articles/PMC7452039/ /pubmed/32874908 http://dx.doi.org/10.1016/j.rmcr.2020.101181 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Roychoudhury, Debasish
Sha, Kenneth
Nanda, Navin C.
Gustafson, Gregory
Enigma of pulmonary hypertension; echocardiography in the crossroads
title Enigma of pulmonary hypertension; echocardiography in the crossroads
title_full Enigma of pulmonary hypertension; echocardiography in the crossroads
title_fullStr Enigma of pulmonary hypertension; echocardiography in the crossroads
title_full_unstemmed Enigma of pulmonary hypertension; echocardiography in the crossroads
title_short Enigma of pulmonary hypertension; echocardiography in the crossroads
title_sort enigma of pulmonary hypertension; echocardiography in the crossroads
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452039/
https://www.ncbi.nlm.nih.gov/pubmed/32874908
http://dx.doi.org/10.1016/j.rmcr.2020.101181
work_keys_str_mv AT roychoudhurydebasish enigmaofpulmonaryhypertensionechocardiographyinthecrossroads
AT shakenneth enigmaofpulmonaryhypertensionechocardiographyinthecrossroads
AT nandanavinc enigmaofpulmonaryhypertensionechocardiographyinthecrossroads
AT gustafsongregory enigmaofpulmonaryhypertensionechocardiographyinthecrossroads